Open AccessSuccessful establishment of a left ventricular assist device program in an emerging country: one year experience
Author(s) -
Emilija Nestorović,
Jan D. Schmitto,
Sudhir S. Kushwaha,
Svetozar Putnik,
Duško Terzić,
Nataša Milić,
Aleksandar Mikić,
Dejan Marković,
D. Trifunović,
Arsen Ristić,
Miljko Ristić
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.04.147
Subject(s) - medicine , ejection fraction , ventricular assist device , adverse effect , ventricle , heart failure , renal function , cardiology , blood urea nitrogen , survival rate , surgery
The primary goal of this study was to evaluate the outcomes of patients with end-stage heart failure (HF) who underwent continuous flow left ventricular assist device (CF-LVAD) in a developing country and to compare to those reported by more developed countries. The secondary goal was on determining factors that may be connected to improved survival.